{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/67a15023f0aed667c52953d7/68e6d5f4f513ad2b81418d6e?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Episode 3 Part 1: Metabolic Health with Dr. Alex Nataros","description":"<p><strong><u>Keywords:</u></strong></p><p>insulin sensitivity, metformin, blood sugar management, dietary approaches, microbiome, GLP-1 agonists, functional medicine, probiotics, metabolic health, clinical signs</p><p><br></p><p><strong><u>Summary:</u></strong></p><p>Episode 3 part 1 covers general metabolic health as it relates to pharmaceuticals, the microbiome and nutrition. My guest is Dr. Alex Nataros, a family doctor practicing in Port Hardy, BC.</p><p><br></p><p><strong><u>Subscribe</u></strong> to the Rings a Bell email list here: https://ringsabellpod.kit.com/subscribe</p><p><br></p><p><strong><u>To become a guest</u></strong> on the show email ringsabellpodcast@gmail.com</p><p><br></p><p><strong><u>References: </u></strong></p><p><strong>Weight Gain Drugs</strong></p><p>https://pmc.ncbi.nlm.nih.gov/articles/PMC6109660/</p><p><strong>Weight loss drugs</strong></p><p><a href=\"https://mobile.fpnotebook.com/Endo/Pharm/MdctnsAsctdWthUntntnlWghtLs.htm\" rel=\"noopener noreferrer\" target=\"_blank\">https://mobile.fpnotebook.com/Endo/Pharm/MdctnsAsctdWthUntntnlWghtLs.htm</a></p><p><strong>Insulin Sensitivity Drugs</strong></p><p>Giglio RV, Papanas N, Rizvi AA, Ciaccio M, Patti AM, Ilias I, Pantea Stoian A, Sahebkar A, Janez A, Rizzo M. An Update on the Current and Emerging Use of Thiazolidinediones for Type 2 Diabetes.&nbsp;<em>Medicina</em>. 2022; 58(10):1475. <a href=\"https://doi.org/10.3390/medicina58101475\" rel=\"noopener noreferrer\" target=\"_blank\">https://doi.org/10.3390/medicina58101475</a></p><p>Laurindo LF, Barbalho SM, Guiguer EL, da Silva Soares de Souza M, de Souza GA, Fidalgo TM, Araújo AC, de Souza Gonzaga HF, de Bortoli Teixeira D, de Oliveira Silva Ullmann T, et al. GLP-1a: Going beyond Traditional Use.&nbsp;<em>International Journal of Molecular Sciences</em>. 2022; 23(2):739. https://doi.org/10.3390/ijms23020739</p><p><a href=\"https://doi.org/10.1016/j.redox.2020.101517\" rel=\"noopener noreferrer\" target=\"_blank\">https://doi.org/10.1016/j.redox.2020.101517</a> (Mechanisms of Action of metformin in type 2 diabetes: effects on mitochondria and leukocyte endothelium interactions.</p><p><strong>Microbiome and obesity:&nbsp;</strong></p><p><a href=\"https://doi.org/10.1016/j.biopha.2022.112678\" rel=\"noopener noreferrer\" target=\"_blank\">https://doi.org/10.1016/j.biopha.2022.112678</a></p><p>Sohail MU, Althani A, Anwar H, Rizzi R, Marei HE. Role of the Gastrointestinal Tract Microbiome in the Pathophysiology of Diabetes Mellitus.&nbsp;<em>J Diabetes Res</em>. 2017;2017:9631435. doi:10.1155/2017/9631435</p><p><strong>HMF Metabolic:</strong></p><p>Michael DR, Jack AA, Masetti G, et al. A randomised controlled study shows supplementation of overweight and obese adults with lactobacilli and bifidobacteria reduces bodyweight and improves well-being.&nbsp;<em>Sci Rep</em>. 2020;10(1):4183. Published 2020 Mar 6. doi:10.1038/s41598-020-60991-7</p><p><strong>UltraFlora Control:</strong></p><p>Stenman LK, Lehtinen MJ, Meland N, et al. Probiotic With or Without Fiber Controls Body Fat Mass, Associated With Serum Zonulin, in Overweight and Obese Adults-Randomized Controlled Trial.&nbsp;<em>EBioMedicine</em>. 2016;13:190-200. doi:10.1016/j.ebiom.2016.10.036</p><p><strong>Super intense study on personalized nutrition published in cell that I talked too long about :) </strong></p><p>Zeevi D, Korem T, Zmora N, et al. Personalized Nutrition by Prediction of Glycemic Responses.&nbsp;<em>Cell</em>. 2015;163(5):1079-1094. doi:10.1016/j.cell.2015.11.001</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p><br></p><p><br></p><p>&nbsp;</p><p>&nbsp;</p>","author_name":"kimberley Kallio"}